Ryo Kobayashi

7PUBLICATIONS
17CO-AUTHORS
Characterisation of biological macromoleculesBehavioural epidemiologyMolecular targetsClinical pharmacy and pharmacy practiceNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 18, 2025
A Consideration of Exploratory Approaches to Comedications Associated With Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy.

Yoshihiro Noguchi, Jifang Zhou, Ryo Kobayashi

|May 01, 2025
Comment on: 'Effects of age, sex, daily dose, comorbidity and co-medication on venlafaxine-associated cardiovascular adverse events: A pharmacovigilance analysis of the FDA adverse event reporting system database'.

Rikuto Masuda, Yoshihiro Noguchi, Ryo Kobayashi

|Oct 29, 2024
Comment on "Postmarketing adverse events of tamoxifen in male and female patients with breast cancer".

Yoshihiro Noguchi, Yoko Ino, Ryo Kobayashi

|Apr 26, 2024
Medication reconciliation by pharmacists for pre-admission patients improves patient safety.

Yunami Yamada, Ryo Kobayashi, Taishi Yamamoto

|Oct 27, 2023
Comparison of the incidence of vancomycin-associated nephrotoxicity following the change from trough-guided dosing to AUC-guided doing using trough-only data.

Yuto Yamada, Takashi Niwa, Yurie Ono

|Jun 26, 2023
Effectiveness of countermeasure for polypharmacy by multidisciplinary team review in patients with diabetes mellitus.

Shohei Nishida, Takehiro Kato, Yuichi Hayashi

Pageof 2

Frequent Collaborators

3 joint publications

Tomoaki Yoshimura

3 joint publications

Yoshihiro Noguchi

2 joint publications

Akio Suzuki

1 joint publications

Shohei Nishida